About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | NK Cells Treatment for COVID-19

NK Cells Treatment for COVID-19

NCT04280224·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Henan Medical University

With

First Affiliated Hospital of Xinjiang Medical University

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

1\. Male or female, aged at 18 years-65 years old
2\. Pneumonia that is judged by chest radiograph or computed tomography
3\. Laboratory confirmation of NCP infection by reverse-transcription polymerase chain reaction(RT-PCR) from any diagnostic sampling source

You may not be if

1\. Pregnancy or breastfeeding
2\. Known HIV, HBV or HCV infection
3\. Patients with malignant tumor, other serious systemic diseases and psychosis
4\. Patients who are participating in other clinical trials
5\. Inability to provide informed consent or to comply with test requirements

The record

StatusCompleted

PhasePhase 1

Taking part2

StartedFeb 2020

UpdatedFeb 8, 2024

Conditions

Novel Coronavirus Pneumonia

Where1

The First Affiliated Hospital of Xinxiang Medical University
Xinxiang, Henan, China